What is the story about?
What's Happening?
Frontiers Health is marking its 10th anniversary with a focus on the commercialization of Health Tech and Deeptech. Pilar Fernández Hermida, founder of i-Expand, discusses strategies for monetizing advanced therapies and foundational technologies like AI. The conversation highlights the importance of making cell and gene therapies (CGTs) more accessible. The event serves as a platform for industry leaders to share insights and strategies for growth in the health technology sector.
Why It's Important?
The commercialization of Health Tech and Deeptech is crucial for advancing medical technologies and improving patient outcomes. By focusing on strategies to monetize these technologies, the conference aims to bridge the gap between innovation and market access. This is particularly significant for emerging therapies and AI applications, which have the potential to revolutionize healthcare delivery. The discussions at Frontiers Health could influence policy decisions and investment strategies, impacting the future of healthcare innovation.
What's Next?
As the conference continues, stakeholders in the health technology sector will likely explore new partnerships and collaborations to advance the commercialization of innovative therapies. The insights shared at Frontiers Health may lead to the development of new business models and strategies for market entry. Attendees and industry leaders will be watching for actionable outcomes that can drive the adoption of advanced health technologies in clinical settings.
AI Generated Content
Do you find this article useful?
